Free daily picks · no account · unsubscribe anytime
Famous investors find the idea. AI times the entry. Free daily picks — every morning at 9 AM ET.
9 swing-trader playbooks for active traders, plus 7 investor playbooks that take great ideas — Pelosi & Congress disclosures, deep-value baggers — and layer AI entry timing on top. You're not copying Pelosi 45 days late; you get a scored, regime-filtered, entry-timed version. No subscription needed.
Recent closed · last 4 wins + last 3 losses · chronological
90d aggregate: 331 trades · 33% win rate · +0.78R avg · see all winners ↓
Pick what you want — change anytime
Free · weekday 9 AM ET · one-click unsubscribe
Educational only — not investment advice.
Trade Like the Pros
Days–weeks timeframe · Entry / stop / target per ticker
Invest Like the Legends
Their best ideas — Pelosi 🏛️, deep-value baggers, quant — scored, regime-filtered, and entry-timed by AI.
Dozens of trackers tell you what Pelosi bought. We tell you when it's a low-risk entry today.
Why Invest Like is different
Great ideas, perfectly timed.
Layer 1 · The idea
Conviction from the people worth copying
Pelosi & Congress disclosures, deep-value baggers — AI scores each pick by how hard the source is leaning on it.
Layer 2 · The timing
AI times the entry — not 45 days late
45+ backtested strategies check today's regime and surface only the picks at a low-risk entry right now. Entry, stop, and target included.
What hits your inbox at 9 AM ET
Here's what subscribers got this morning
Real tickers, real levels — screened overnight by the agents.
Stage 2 Cycle Trader
Entry
$42.96
Stop
$40.43
Target
$50.55
Seasoned Swing
Entry
$38.71
Stop
$37.08
Target
$41.97
Wyckoff
Entry
$94.50
Stop
$90.50
Target
$104.50
Wyckoff
Entry
$89.50
Stop
$85.50
Target
$99.50
📈 Thu picks: Wyckoff accumulation + Six Sigma adds
Six7 Alpha <picks@six7alpha.com> · to you · 9:00 AM
| Symbol | Entry | Stop | Target | R:R | Risk |
|---|---|---|---|---|---|
| VERA | $42.96 | $40.43 | $50.55 | 3.0R | 5.9% |
| AROC | $38.71 | $37.08 | $41.97 | 2.0R | 4.2% |
| SYRE | $94.50 | $90.50 | $104.50 | 2.5R | 4.2% |
Want more control?
Meet the Agent.
Pick your strategy, screen real tickers, build a full trade plan — every step transparent.
- Famous picks (Pelosi, deep-value baggers) + AI entry timing — 9 trader & 7 investor playbooks, 45 strategies underneath
- Real screeners, not hallucinated tickers
- Full chain visible: diagnose → select → screen → rank → plan
Recent winners · 90-day window
| Ticker | Playbook | R | Closed |
|---|---|---|---|
| SJM | Seasoned Swing | +0.22R | 2026-07-09 |
| PENN | Seasoned Swing | +0.53R | 2026-07-08 |
| INTC | Wyckoff | +0.31R | 2026-07-02 |
| GTX | Seasoned Swing | +0.74R | 2026-07-02 |
| COHR | Weinstein | +303.41R | 2026-07-01 |
We show losers too. Real stops, real outcomes — not cherry-picked highlights.
90-day window across all 9 trader + 7 investor playbooks. Past performance does not guarantee future results. Not investment advice.
Today's Invest Like Picks · Live
These came from real investor watchlists — AI says when to enter, in the free daily email · see all picks →
How it works
Pick your path
Trade Like for active traders, Invest Like for investors, or The Agent for full control.
Get daily picks
AI screens every morning. Email at 9 AM ET — or use The Agent on-demand.
See the full analysis
Click through for levels, history, and conviction ranking — every step is visible.
We publish every loss
Real stops, real R-multiples. No hidden track record.
Not a registered advisor
Educational research, not personalized financial advice.
Real screeners, not guesses
Every ticker from code-driven filters on live data.
Educational, not advisory
Research tool, not a broker. You make every decision.
Start with free daily picks
Built on 3 years of strategy backtesting across 20 benchmark tickers — picks delivered every weekday morning.
Free — no credit card required.
Educational only · Not a registered investment advisor
Six7 Alpha provides information for educational purposes only and does not constitute financial advice. Past performance is not indicative of future results.